Kieron M. Dunleavy, MD, on Lymphomas: Genomics and Genetics
2016 Pan Pacific Lymphoma ConferenceKieron M. Dunleavy, MD, of the National Cancer Institute, discusses the genomic landscape of aggressive lymphomas and how this is informing therapy decisions.
Related Videos
Julie M. Vose, MD, MBA, on Basket Trials
Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, discusses this evolution of clinical trials, and using genomic methods to direct therapy.
Wyndham H. Wilson, MD, PhD, on Treating Diffuse Large B-Cell Lymphoma
Wyndham H. Wilson, MD, PhD, of the National Cancer Institute, discusses the molecular underpinnings of diffuse large B-cell lymphoma and targeted treatments.
John G. Gribben, MD, DSc, on Follicular Lymphoma: Still a Role for Transplant?
John G. Gribben, MD, DSc, of Barts Cancer Institute, discusses the pros and cons of both autologous and allogeneic stem cell transplantation in follicular lymphoma, and the challenges...
Fredrick B. Hagemeister, Jr, MD, on Using Rituximab Maintenance
Fredrick B. Hagemeister, Jr, MD, of the University of Texas MD Anderson Cancer Center, discusses whether rituximab maintenance should be used in indolent lymphomas other than follicul...
Julie M. Vose, MD, MBA, on Highlights of Pan Pacific Lymphoma 2016
Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, discusses the key presentations at the 2016 Pan Pacific Lymphoma Conference.
